ResMed (RMD) PT Raised to $266 at KeyBanc

October 25, 2024 7:30 AM EDT
Get Alerts RMD Hot Sheet
Price: $224.46 -1.01%

Rating Summary:
    11 Buy, 12 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
KeyBanc analyst Brett Fishbin raised the price target on ResMed (NYSE: RMD) to $266.00 (from $251.00) while maintaining a Overweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change